LRP6 and neoplasm: The tumor suppressive gene retinoic acid receptor responder 3(RARRES3) has been proved to inhibit cancer stem cell properties in breast cancer via targeting and modulating the acylation status of Wnt ligands and the co-receptor LRP6 [33].